Skip to main content
Diana Do, MD, Ophthalmology, Stanford, CA

Diana Van Do MD

Cataract Related, Retinal Disease


Professor of Ophthalmology, Vice Chair for Clinical Affairs, Byers Eye Institute, Stanford University School of Medicine

Join to View Full Profile
  • 300 Pasteur DrStanford, CA 94305

  • Phone+1 650-723-4000

Dr. Do is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Diana V. Do, MD, is Professor of Ophthalmology and Vice Chair for Clinical Affairs at the Byers Eye Institute at Stanford University School of Medicine. She has over 15 years of experience as a retinal surgeon. In addition, she is a physician-scientist who is a leader in clinical research and clinical trials of retinal vascular diseases.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Surgical Retina and Vitreous, 2003 - 2005
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Ophthalmology, 2000 - 2003
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalInternship, Internal Medicine, 1999 - 2000
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2026
  • NE State Medical License
    NE State Medical License 2013 - 2018
  • MD State Medical License
    MD State Medical License 2003 - 2014
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • AMD, DME Therapies Aimed at Reducing Treatment Burden Shine at AAO 2024
    AMD, DME Therapies Aimed at Reducing Treatment Burden Shine at AAO 2024November 1st, 2024
  • The Status of Gene Therapy Development for Retinal Diseases
    The Status of Gene Therapy Development for Retinal DiseasesApril 30th, 2024

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: